• 1
    Baker R, Grol R. Quality Improvement. Principles and models for quality improvement Primary Care Medicine. Oxford: 2004: 459–464.
  • 2
    Lee TH. Measurement and improvement of quality of cardiovascular care. In: Braunwald D, Zipes DP, Libby P, et al, eds. Braunwalds HeartDisease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, PA: Elsevier Saunders; 2005:3542.
  • 3
    Measuring and improving quality of care: a report from the American Heart Association/ American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation. 2000;101:14831493.
  • 4
    Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/ American College of Cardiology First Scientific Forum of Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. Circulation. 2003;107:16811691.
  • 5
    Marwick J, Grol R, Borgiel A. Quality Assurance for Family Doctors.Report of the Quality Assurance Working Party of the World Organization of Family Doctors. Jolimont, Australia: WONCA, 1992.
  • 6
    Marshall MN, Shekelle PG, Leatherman S, et al. The public release of performance data: what do we expect to gain? A review of the evidence. JAMA. 2000;283:18661874.
  • 7
    Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 2001 summary. Adv Data. 2003;337:144.
  • 8
    Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398404.
  • 9
    Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287:10031010.
  • 10
    Jones DW, Hall JE. The National High Blood Pressure Education Program: thirty years and counting. Hypertension. 2002;39: 941942.
  • 11
    Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:16511662.
  • 12
    Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke. 2006;37: 345350.
  • 13
    Rosamond W, Flegal K, Friday G, et al. Circulation. 2007;115: e69171.
  • 14
    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:25602572.
  • 15
    The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:14621536.
  • 16
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285: 24862497.
  • 17
    Division of Mental Health, World Health Organization. Field Trial WHOQOL-100. Facet Definitions and Questions. February 1995.
  • 18
    Tzinieri-Kokotsi M, Triantafyllou E, Antonopoulou B, Tomaras B, Christodoulou GN. Manual of Quality of Life Based on WHOQOL-100. Psychiatric Clinic, Aiginiteio hospital, University of Athens Greece, BHTA medical arts Athens 2003;848.
  • 19
    Andrade SE, Gurwitz JH, Field TS, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481486.
  • 20
    Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413420.
  • 21
    Alexander M, Tekawa I, Hunkeler E, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999;159:26732677.
  • 22
    Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:19571963.
  • 23
    Knight EL, Bohn RL, Wang PS, et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38: 809814.
  • 24
    Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:22812286.
  • 25
    Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825834.
  • 26
    Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs. Lancet. 2000;356:19551964.
  • 27
    Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension. 2005;46: 280286.
  • 28
    Hajjar I, Kotchen TA. Trends in prevalence, treatment, and control of hypertension in the United States, 1998–2000. JAMA. 2003;290:199206.
  • 29
    National Committee for Quality Assurance. The health plan employer data and information set (HEDIS). Available at: Accessed November 15, 2003.
  • 30
    Godley P, Nguyen A, Yokoyama K, et al. Improving hypertension care in a large group-model MCO. Am J Health Syst Pharm. 2003;60:554564.
  • 31
    McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:26352645.